UroGen Pharma Ltd. (URGN)
36.58
-1.68
(-4.39%)
USD |
NASDAQ |
Oct 14, 16:00
36.59
+0.01
(+0.03%)
Pre-Market: 20:00
UroGen Pharma Total Long Term Debt (Quarterly) : 195.44M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 195.44M |
| March 31, 2026 | 196.50M |
| December 31, 2025 | 129.61M |
| September 30, 2025 | 129.51M |
| June 30, 2025 | 126.80M |
| March 31, 2025 | 125.73M |
| December 31, 2024 | 124.13M |
| September 30, 2024 | 121.92M |
| June 30, 2024 | 98.24M |
| March 31, 2024 | 98.23M |
| December 31, 2023 | 99.40M |
| September 30, 2023 | 99.54M |
| June 30, 2023 | 99.50M |
| March 31, 2023 | 99.34M |
| December 31, 2022 | 99.12M |
| September 30, 2022 | 73.73M |
| June 30, 2022 | 72.71M |
| March 31, 2022 | 71.07M |
| December 31, 2021 | 0.398M |
| Date | Value |
|---|---|
| September 30, 2021 | 0.616M |
| June 30, 2021 | 0.922M |
| March 31, 2021 | 1.201M |
| December 31, 2020 | 1.497M |
| September 30, 2020 | 1.748M |
| June 30, 2020 | 1.994M |
| March 31, 2020 | 2.268M |
| December 31, 2019 | 2.604M |
| September 30, 2019 | 1.749M |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Xencor, Inc. | 166.19M |
| MeiraGTx Holdings Plc | 110.06M |
| Insmed, Inc. | 741.01M |
| Ironwood Pharmaceuticals, Inc. | 393.58M |
| Viking Therapeutics, Inc. | 3.925M |